Continuous monitoring of genetic and antigenic changes in PEDV strains is critical to control epidemic outbreaks and for vaccine development (Chattha et al., 2015; Mumford, 2007) . However, there are limitations in the comprehensive characterization of antigenic variations among PEDV strains, although cross-protection activity is a primary criterion for vaccine strain selection, and immunity is thought to be a major driving force of virus evolution.